Trillitye Paullin

Chief Science Officer
All articles by 
Trillitye Paullin
What Is a 361 vs. 351 Product? Understanding FDA Regulation of Human Cells and Tissues
Inside the Lab: Functional Characterization of Amniotic Fluid-Derived Products
Debunking the “COVID Vaccine-Free” Claim in Regenerative Medicine: What the Science and Regulations Actually Say
The Species Gap: Why Plant-Based Biologics Don’t Translate in Human Therapies
What Does "Culture and Expanded" Really Mean in Regenerative Medicine?
Choosing the Right Storage for Biologic Products: Why -80°C Is Ideal for Acellular Exosome-Based Therapies
Proteomics 101: Unlocking the Secrets of Proteins in Health and Disease
Peptides and Extracellular Vesicles: The Next Revolution in Skin Rejuvenation Beyond Polynucleotides
The Role of Exosomes in Cellular Communication and Therapeutic Potential
Cell-Cell Signaling and Inflammation: A Molecular Perspective on Healing and Regeneration
Molecular Components of Amniotic Fluid: Unlocking Potential for Regenerative Medicine
Exploring New Horizons in Peptide Therapeutics: Opportunities and Innovations
The Future of Regenerative Medicine: A Comprehensive Guide for Healthcare Providers
COVID-19 Vaccination and Tissue Transplantation: Addressing Concerns for Medical Providers
Could Amniotic Fluid Be the Secret to Safe Regeneration?